Honey as an antiviral agent against respiratory syncytial virus [PDF]
Respiratory syncytial virus is the most frequent cause of hospitalization for viral respiratory infections in infants and young children worldwide. It also severely affects immunocompromised adults and the elderly, however, despite decades of efforts ...
Zareie, Parvaneh Palma
core
A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus [PDF]
Human and bovine respiratory syncytial viruses (HRSV and BRSV) are two closely related, worldwide prevalent viruses that are the leading cause of severe airway disease in children and calves, respectively.
Dubuquoy, Catherine, C. +18 more
core +1 more source
Incidence and risk factors for respiratory syncytial virus and human metapneumovirus infections among children in the remote highlands of Peru [PDF]
The disease burden and risk factors for respiratory syncytial virus (RSV) and human metapneumovirus (MPV) infections among children living in remote, rural areas remain unclear.; We conducted a prospective, household-based cohort study of children aged ...
Gil, Ana I. +48 more
core +2 more sources
Modeling household dynamics on Respiratory Syncytial Virus (RSV) [PDF]
Respiratory Syncytial Virus (RSV) is the most common cause of respiratory tract infection in infants and children and shows increasing trend among elderly people worldwide. In many developing country settings, population and household structures have gone through some significant changes in the past decades, namely fewer births, more elderly population,
Mahikul, W +7 more
openaire +4 more sources
Prevalence of human respiratory syncytial virus circulating in Iran
Summary: Respiratory syncytial virus (RSV) is a leading cause of acute respiratory infection during early childhood and is associated with a great burden on patients, parents, and society.
Vahid Salimi +4 more
doaj +1 more source
IRIS: Infection with RespIratory Syncytial Virus in infants—a prospective observational cohort study
Background Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory tract infection in infants. Globally, RSV is responsible for approximately 3.2 million hospital admissions and about 60,000 in-hospital deaths per year ...
Martin Wetzke +11 more
doaj +1 more source
Julia Dvorkin,1,2 Julián De Luca,1 Damian Alvarez-Paggi,1,2 Mauricio T Caballero1,2 1Fundación INFANT, Buenos Aires, Argentina; 2Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, ArgentinaCorrespondence: Mauricio T ...
Dvorkin J +3 more
doaj
Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge. [PDF]
Intramuscular (IM) vaccination with formalin-inactivated respiratory syncytial virus (FI-RSV) failed in clinical trials due to vaccine-enhanced respiratory disease.
Soojin Park +10 more
doaj +1 more source
The Changing Landscape of Respiratory Syncytial Virus Infections
Respiratory syncytial virus (RSV), a negative-sense, enveloped RNA virus of the family Paramyxoviridae, subfamily Pneumovirinae, and genus Pneumovirus, is the single most important respiratory pathogen affecting infants and young children [...]
Reinout A. Bem, Job B. M. van Woensel
doaj +1 more source
Development of a safe and efficacious vaccine for respiratory syncytial virus (RSV) has been challenging. Here the authors generate a live-attenuated RSV vaccine that shows increased thermostability and immunogenicity, and protects cotton rats from RSV ...
Christopher C. Stobart +20 more
doaj +1 more source

